Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,535Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2AbbVie Inc

02 3Aspen Pharmacare Holdings

03 2Alembic Pharmaceuticals Limited

04 2Apotex Inc

05 2Aurobindo Pharma Limited

06 4CPS Cito Pharma Services GmbH

07 2Cipla

08 2ENDO OPERATIONS

09 2Inventia Healthcare Limited

10 2JAMP PHARMA

11 2Jubilant Generics

12 6Macleods Pharmaceuticals Limited

13 2Meru Labs Luxco S.à rl,

14 6Merus Labs Luxco S. à R. L.

15 2PolyGen Pharmaceuticals

16 2SEARCHLIGHT PHARMA INC

17 2Torrent Pharmaceuticals Limited

18 2Xiromed

19 8Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : ENABLEX

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-12-22

Application Number : 21513

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

02

arrow
CPhI India 2024
Not Confirmed

Darifenacin Hydrobromide

Brand Name : Enablex 7,5mg

Dosage Form : TAB

Dosage Strength : 7.5mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

03

arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : ENABLEX

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2004-12-22

Application Number : 21513

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

04

arrow
CPhI India 2024
Not Confirmed

Darifenacin Hydrobromide

Brand Name : Enablex 7,5mg

Dosage Form : TAB

Dosage Strength : 7.5mg

Packaging : 14X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

05

arrow
CPhI India 2024
Not Confirmed

Darifenacin Hydrobromide

Brand Name : Enablex 15mg

Dosage Form : TAB

Dosage Strength : 15mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2017-12-08

Application Number : 207681

Regulatory Info : RX

Registration Country : USA

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2017-12-08

Application Number : 207681

Regulatory Info : RX

Registration Country : USA

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2016-09-19

Application Number : 206743

Regulatory Info : RX

Registration Country : USA

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2016-09-19

Application Number : 206743

Regulatory Info : RX

Registration Country : USA

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2016-09-01

Application Number : 207664

Regulatory Info : RX

Registration Country : USA

blank

11

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2016-09-01

Application Number : 207664

Regulatory Info : RX

Registration Country : USA

blank

12

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2016-10-12

Application Number : 205550

Regulatory Info : DISCN

Registration Country : USA

blank

13

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2016-10-12

Application Number : 205550

Regulatory Info : DISCN

Registration Country : USA

blank

14

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2017-07-28

Application Number : 207302

Regulatory Info : RX

Registration Country : USA

blank

15

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2017-07-28

Application Number : 207302

Regulatory Info : RX

Registration Country : USA

blank

16

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Darifenacin

Brand Name :

Dosage Form : ER TABLET

Dosage Strength : 7.5MG

Packaging :

Approval Date :

Application Number : 91190

Regulatory Info : Generic US CTD

Registration Country : United Kingdom

blank

17

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Darifenacin

Brand Name :

Dosage Form : ER TABLET

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 91190

Regulatory Info : Generic US CTD

Registration Country : United Kingdom

blank

18

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2020-01-06

Application Number : 211045

Regulatory Info : RX

Registration Country : USA

blank

19

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2020-01-06

Application Number : 211045

Regulatory Info : RX

Registration Country : USA

blank

20

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2016-11-17

Application Number : 205209

Regulatory Info : RX

Registration Country : USA

blank

21

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2016-11-17

Application Number : 205209

Regulatory Info : RX

Registration Country : USA

blank

22

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2019-10-22

Application Number : 209571

Regulatory Info : DISCN

Registration Country : USA

blank

23

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2019-10-22

Application Number : 209571

Regulatory Info : DISCN

Registration Country : USA

blank

24

ENDO OPERATIONS

Country
CPhI India 2024
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 7.5MG BASE

Packaging :

Approval Date : 2015-03-13

Application Number : 91190

Regulatory Info : DISCN

Registration Country : USA

blank

25

ENDO OPERATIONS

Country
CPhI India 2024
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
CPhI India 2024
Not Confirmed

DARIFENACIN HYDROBROMIDE

Brand Name : DARIFENACIN HYDROBROMIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2015-03-13

Application Number : 91190

Regulatory Info : DISCN

Registration Country : USA

blank

26

Meru Labs Luxco S.à rl,

Country
CPhI India 2024
Not Confirmed
arrow

Meru Labs Luxco S.à rl,

Country
arrow
CPhI India 2024
Not Confirmed

darifenacin hydrobromide

Brand Name : Emselex

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 7.5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

27

Meru Labs Luxco S.à rl,

Country
CPhI India 2024
Not Confirmed
arrow

Meru Labs Luxco S.à rl,

Country
arrow
CPhI India 2024
Not Confirmed

darifenacin hydrobromide

Brand Name : Emselex

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

28

Merus Labs Luxco S. à R. L.

Country
CPhI India 2024
Not Confirmed
arrow

Merus Labs Luxco S. à R. L.

Country
arrow
CPhI India 2024
Not Confirmed

Darifenacin

Brand Name : Emselex

Dosage Form : Depottablett

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

29

Merus Labs Luxco S. à R. L.

Country
CPhI India 2024
Not Confirmed
arrow

Merus Labs Luxco S. à R. L.

Country
arrow
CPhI India 2024
Not Confirmed

Darifenacin

Brand Name : Emselex

Dosage Form : Depottablett

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

30

Merus Labs Luxco S. à R. L.

Country
CPhI India 2024
Not Confirmed
arrow

Merus Labs Luxco S. à R. L.

Country
arrow
CPhI India 2024
Not Confirmed

Darifenacin

Brand Name : Emselex

Dosage Form : Depottablett

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank